Your browser doesn't support javascript.
loading
Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group.
Rigolin, Gian Matteo; Cavazzini, Francesco; Piciocchi, Alfonso; Arena, Valentina; Visentin, Andrea; Reda, Gianluigi; Zamprogna, Giulia; Cibien, Francesca; Vitagliano, Orsola; Coscia, Marta; Farina, Lucia; Gaidano, Gianluca; Murru, Roberta; Varettoni, Marzia; Paolini, Rossella; Sportoletti, Paolo; Pietrasanta, Daniela; Molinari, Anna Lia; Quaglia, Francesca M; Laurenti, Luca; Marasca, Roberto; Marchetti, Monia; Mauro, Francesca R; Crea, Enrico; Vignetti, Marco; Gentile, Massimo; Montillo, Marco; Foà, Robin; Cuneo, Antonio.
Affiliation
  • Rigolin GM; Department of Medical Sciences, Hematology Section, University of Ferrara, Cona - Ferrara, Italy.
  • Cavazzini F; Department of Medical Sciences, Hematology Section, University of Ferrara, Cona - Ferrara, Italy.
  • Piciocchi A; GIMEMA Foundation, Rome, Italy.
  • Arena V; GIMEMA Foundation, Rome, Italy.
  • Visentin A; Department of Medicine, Hematology and Clinical Immunology Unit, University of Padua, Padua, Italy.
  • Reda G; Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy.
  • Zamprogna G; Hematology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cibien F; Hematology, Ospedale Ca' Foncello, Treviso, Italy.
  • Vitagliano O; Hematology, Cardarelli Hospital, Naples, Italy.
  • Coscia M; Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.
  • Farina L; Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy.
  • Gaidano G; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Milano, Italy.
  • Murru R; Department of Translational Medicine, Division of Hematology, Università del Piemonte Orientale, Novara, Italy.
  • Varettoni M; Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS "G. Brotzu", Cagliari, Italy.
  • Paolini R; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Sportoletti P; Hematology Unit, Rovigo General Hospital, Rovigo, Italy.
  • Pietrasanta D; Department of Medicine and Surgery, Institute of Hematology and Centre for Hemato-Oncological Research, Ospedale S. Maria della Misericordia, Perugia, Italy.
  • Molinari AL; Hematology Division, Dipartimento Internistico Struttura Complessa di Ematologia Ospedale civile SS Antonio e Biagio, Alessandria, Italy.
  • Quaglia FM; Hematology, Ospedale degli Infermi, Rimini, Italy.
  • Laurenti L; Department of Medicine, Section of Hematology, University of Verona, Verona, Italy.
  • Marasca R; Fondazione Policlinico Universitario A Gemelli. Roma IRCCS, Rome, Italy.
  • Marchetti M; Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy.
  • Mauro FR; Oncology Unit, Cardinal Massaia Hospital, Asti, Italy.
  • Crea E; Department of Translational and Precision Medicine, Hematology, 'Sapienza' University, Rome, Italy.
  • Vignetti M; GIMEMA Foundation, Rome, Italy.
  • Gentile M; GIMEMA Foundation, Rome, Italy.
  • Montillo M; Department of Onco-Hematology, Hematology Unit, A.O. of Cosenza, Cosenza, Italy.
  • Foà R; Hematology, Niguarda Cancer Centre, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Cuneo A; Department of Translational and Precision Medicine, Hematology, 'Sapienza' University, Rome, Italy.
Hematol Oncol ; 39(3): 326-335, 2021 Aug.
Article in En | MEDLINE | ID: mdl-33739461

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Hematol Oncol Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United kingdom